Ama­zon sub­sidiary Pill­Pack reach­es a set­tle­ment with US gov­ern­ment and will have to shell out over $5.6M

Ama­zon’s on­line phar­ma­cy has set­tled a law­suit in New York af­ter al­le­ga­tions of over­billing for the life­sav­ing drug in­sulin.

The set­tle­ment re­solves al­le­ga­tions that the phar­ma­cy, known as Pill­Pack, im­prop­er­ly billed gov­ern­ment health­care pro­grams like Medicare and Med­ic­aid for more in­sulin pens than pa­tients need­ed ac­cord­ing to their pre­scrip­tions, and for false­ly un­der-re­port­ing the days in­sulin sup­plies were dis­pensed.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.